Category: Featured

Australian Icannex (IHL:ASX) Headed to NASDAQ?

Incannex completes Phase 2 trial for its cannabinoid drug for sleep apnea, flags Nasdaq listing in 2022 With Phase 2 dosing complete,...

Testimonial: The Ibogaine Clinic, Playa Del Carmen

VIDEO TESTIMONIALS https://youtu.be/hrrLoxuR2oo VISIT WEBSITE

Small Pharma (DMT, DMTTF) $0.46 a Small and Extremely Interesting Psychedelic Company.

Conference Call Today at 12:00 EST. As the TSX chart above show, investors appear to be warming up the the idea. Not many investors...

Mindcure (MCURF) and Awakn Life Sciences (AWKNF) Seek to Distribute Ketamine Protocol for Alcohol Use Disorder.

MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE's Digital Therapeutics Platform

Ft. Lauderdale Boat Show

Ft. Lauderdale Boat ShowOctober 27 - 31, 2021 Pila Pexton Yacht Charter SpecialistMerle Wood & Associates, Inc.Direct +1 401.862.1977   Office +1 401.619.4111  pilapexton@merlewood.com

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

Shark Tank’s Kevin O’Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr. Sharmin Ghaznavi. Recent Wall Street...

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most. The Psychedelic Renaissance is roaring. Over the past...

2021 Psychedelic Investor Guide Released.

Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the most comprehensive and easy to use guide covering...
Most Popular

Mystery Solved. Threshold Bioscience’s Neuroblo-Ibogaine!

500mg Iboga Total Alkaloid (TA) Extract. Someone posted this photo on LinkedIn, which we took as a tease....

$400 Million Man Tries Psychedelic Toads.

"This was the most profound experience of my life. I am stunned beyond comprehension. This molecule is without peer."

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

The Montgomery-Asberg Depression Rating Scale. We were flying from Hawaii to Las Vegas yesterday and when we landed,...